•
Sep 30, 2023

Natera Q3 2023 Earnings Report

Delivered robust volume and revenue growth while demonstrating operational discipline with a significant reduction in cash burn.

Key Takeaways

Natera reported a 27.4% increase in total revenues, reaching $268.3 million, driven by a 32.7% increase in product revenues. The company processed approximately 626,000 tests, reflecting a 21.0% increase. They have revised their 2023 annual revenue guidance to $1.035 billion to $1.05 billion.

Total revenues were $268.3 million, a 27.4% increase compared to Q3 2022.

Product revenues increased by 32.7% to $265.2 million.

Approximately 626,000 tests were processed, a 21.0% increase from the previous year.

Net loss was $109.0 million, or ($0.95) per diluted share.

Total Revenue
$268M
Previous year: $211M
+27.4%
EPS
-$0.95
Previous year: -$1.25
-24.0%
Tests Processed
626K
Previous year: 517.5K
+21.0%
Tests Accessioned
609.8K
Previous year: 502.9K
+21.3%
Total Tests Reported
590K
Previous year: 483K
+22.2%
Gross Profit
$121M
Previous year: $94.1M
+28.6%
Cash and Equivalents
$937M
Previous year: $521M
+79.7%
Free Cash Flow
-$38.7M
Previous year: -$114M
-66.2%
Total Assets
$1.45B
Previous year: $1.01B
+43.3%

Natera

Natera

Forward Guidance

Natera is revising its 2023 annual guidance. The Company now expects annual revenue to be in a range of $1.035 billion to $1.05 billion, up from its previous range of $1.015 billion to $1.035 billion; and gross margin to be in a range of approximately 43% to 44% of revenues, revised from its previous range of 41% to 44%. In addition, net cash consumption is now expected to be approximately $260 million to $280 million, down from its previous range of $300 million to $325 million.